July 9, 2012 — Miracor Medical Systems GmbH announced that the first three ST segment elevation myocardial infarction (STEMI) patients enrolled in its “Prepare RAMSES” nonrandomized safety and feasibility study of 40 patients have been successfully treated using PICSO (pressure-controlled intermittent coronary sinus occlusion) for 90 minutes following primary PCI (percutaneous coronary intervention, or angioplasty) of the left anterior descendens (LAD) coronary artery.

July 9, 2012 — Endosystems Inc., a medical device company developing technology for endovascular aneurysm repair (EVAR), announced closing on $25 million of equity financing. Synergy Life Science Partners, a new investor, led the round and was joined by existing investors US Venture Partners and Longitude Capital Management. Mudit K. Jain, Ph.D., partner at Synergy Life Science Partners, will join the company’s board of directors.

July 9, 2012 — GE Healthcare unveiled in June the GE Blueprint for low dose, a comprehensive program that helps healthcare providers integrate CT (computed tomography) technologies, education and process improvements, and data analysis to reduce patient radiation dose from CT by up to 50 percent.

July 6, 2012 — Vascular Closure Systems Inc. announced that the 30-day follow-up results for the Phase I first-in-human (FIH) clinicals have been confirmed by Doppler and ultrasound evaluation. The evaluation confirmed normal vessel healing, with complete absorption of the FastSeal sealing element.

July 5, 2012 — Avinger Inc., a medical device manufacturer of multifunctional catheters, announced in June that it has successfully completed enrollment in its CONNECT II global clinical trial.

July 3, 2012 — The Supreme Court ruling upholding the Affordable Care Act gives extra punch to the market forces pushing healthcare away from fee-for-service and re-injects a new sense of urgency into the transformation of the health industry, according to a report published today by the Health Research Institute (HRI) of PwC US.